Advertisement
Journal Home
Search for

Volume 111, Issue 1, Pages 83-86 (January 2009)


View previous. 14 of 20 View next.

Leber’s optic neuropathy associated with disseminated white matter disease: A case report and review

F. Pereza, O. Anneb, S. Debruxellesa, P. Menegonc, V. Lambrecqa, D. Lacombeef, M.L. Martin-Negrierd, B. Brocheta, C. GoizetaefCorresponding Author Informationemail address

Received 23 January 2008; received in revised form 24 June 2008; accepted 30 June 2008.

Abstract 

Leber’s hereditary optic neuropathy (LHON), a mitochondrial disease, is clinically characterized by a bilateral subacute loss of central vision consecutive to optic nerve involvement. In some cases of LHON, neurological features are reported including multiple sclerosis-like (MSL) phenotype. We report one additional male patient displaying LHON-MSL associated with the prevalent G11778A mutation and review the cases with expendable data published so far in the literature. We discuss the respective roles of inflammation and energetic metabolism dysregulation in the development of brain lesions. We propose to treat these patients early with both antioxidative and immunosuppressive drugs in order to avoid further handicap.

a CHU Bordeaux, Fédération des Neurosciences Cliniques, Hôpital Pellegrin, 33076 Bordeaux, France

b Département de Neurologie, CHR de la Rochelle, 17019 La Rochelle, France

c CHU Bordeaux, Service de Neuroradiologie, Hôpital Pellegrin, 33076 Bordeaux, France

d CHU Bordeaux, Département de Neuropathologie, Hôpital Pellegrin, 33076 Bordeaux, France

e CHU Bordeaux, Service de Génétique Médicale, Hôpital Pellegrin-enfants, 33076 Bordeaux, France

f Université Victor Segalen Bordeaux 2, Laboratoire de Génétique Humaine, 33076 Bordeaux, France

Corresponding Author InformationCorresponding author at: Laboratoire de Génétique Humaine, Université Victor Segalen Bordeaux 2, 33076 Bordeaux cedex, France. Tel.: +33 661523665.

PII: S0303-8467(08)00263-1

doi:10.1016/j.clineuro.2008.06.021


View previous. 14 of 20 View next.

Advertisement